A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

出版年份 2020 全文链接

标题

作者

关键词

immunotherapy, epitope spread, metastatic cancer, NEO-PV-01, cancer vaccine, T cell, neoantigen, personalized vaccine, checkpoint inhibitor, anti-PD-1

出版物

CELL

Volume 183, Issue 2, Pages 347-362.e24

出版商

Elsevier BV

发表日期

2020-10-15

DOI

10.1016/j.cell.2020.08.053

向作者/读者发起求助以获取更多资源

Protocol

在线求助

Reagent

在线求助

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started